name: PROMIS short form - upper extremity 7a - version 2.0


name: PROMIS short form - upper extremity 7a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - coping expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Date range for emergency response plan:DateRange:Pt:^Event:Qn


name: Microbiology - bacterial studies:Find:Pt:^Patient:Doc


name: Microbiology - parasitic studies:Find:Pt:^Patient:Doc


name: Donor contact information panel:-:Pt:^Donor:-


name: Has infectious disease or illness:Find:Pt:^Patient:Ord


name: Has valid driver license:Find:Pt:^Patient:Ord


name: PROMIS smoking - emotional and sensory expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - negative health expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - negative psychosocial expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - nicotine dependence for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Residence renovation completion date:Date:Pt:^Patient:Qn


name: Residence renovation start date:Date:Pt:^Patient:Qn


name: Resident of region that is endemic for the disease of interest:Find:Pt:^Patient:Ord


name: STarT Back Screening Tool panel:-:Pt:^Patient:-:STarT Back


name: State where healthcare received outside resident state:Loc:Pt:^Patient:Nom


name: PROMIS dyspnea severity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS item bank - dyspnea severity - version 1.0


name: Ambulatory blood pressure monitor study:Find:Pt:^Patient:Doc


name: Key words related to public health emergency:Find:Pt:^Event:Nom


name: PhenX - body proportions protocol 220201:-:Pt:^Patient:-:PhenX


name: PhenX - body proportions protocol 220201


name: Heel-shin slide - left:Score:Pt:^Patient:Ord


name: Heel-shin slide - right:Score:Pt:^Patient:Ord


name: Response team name:ID:Pt:EMS response:Nom


name: PROMIS item bank - dyspnea severity - version 1.0:-:7 days:^Patient:-:PROMIS


name: PROMIS item bank - mobility - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - mobility - version 2.0


name: PROMIS item bank - physical function - version 2.0


name: PROMIS item bank - physical function - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing daily activities - version 1.0


name: PROMIS item bank - self-efficacy for managing daily activities - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing emotions - version 1.0


name: PROMIS item bank - self-efficacy for managing emotions - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS short form - physical function 10a - version 2.0


name: PROMIS short form - physical function 10a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 10b - version 2.0


name: PROMIS short form - physical function 10b - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - physical function 10b - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS parent proxy strength impact - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS pediatric fatigue - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: Substance with 4-hydroxyphenylpyruvate dioxygenase inhibitor mechanism of action (substance)


name: 4-hydroxyphenylpyruvate dioxygenase inhibitor (disposition)


name: Substance with interleukin 6 receptor antagonist mechanism of action (substance)


name: Interleukin 6 receptor antagonist (disposition)


name: Duke Treadmill Score panel:-:Pt:^Patient:-:DTS


name: Duke Treadmill Score risk level:Imp:Pt:^Patient:Ord:DTS


name: E Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little e Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: E Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: little e Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Rules for using smoked tobacco products inside home


name: Rules for using smoked tobacco products inside home:Find:Pt:^Patient:Nom


name: Rules for using smokeless tobacco products inside home


name: Rules for using smokeless tobacco products inside home:Find:Pt:^Patient:Nom


name: Physical security assessment system details


name: Physical security assessment system details:Find:Pt:^Event:Nar


name: Physical security assessment system name:Type:Pt:^Event:Nom


name: Physical security assessment system name


name: Physical security assessment system type


name: Physical security assessment system type:Type:Pt:^Event:Nom


name: PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0


name: PROMIS item bank - self-efficacy for managing social interactions - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing social interactions - version 1.0


name: PROMIS item bank - self-efficacy for managing symptoms - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing symptoms - version 1.0


name: PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS pediatric anxiety - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric asthma impact - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: Lab observation result status:Type:Pt:^Patient:Nom


name: Lab order result status:Type:Pt:^Patient:Nom


name: ABCB1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Labor and delivery admission history and physical - recommended IHE set


name: Labor and delivery admission history and physical - recommended IHE set:-:Pt:{Setting}:-


name: Labor and delivery summary - recommended IHE set


name: Labor and delivery summary - recommended IHE set:-:Pt:{Setting}:-


name: PROMIS smoking - social motivations for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS upper extremity version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: S Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little s Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: S Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: little s Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Scale for the Assessment and Rating of Ataxia


name: Physical therapy goal attainment expected duration - time frame:Time:Pt:^Patient:Qn


name: Physical therapy goal attainment expected duration - time frame


name: Physical therapy goal attainment expected duration - visits:Num:Pt:^Patient:Qn


name: Physical therapy goal attainment expected duration - visits


name: Physical therapy goals panel:-:Pt:^Patient:-


name: Physical therapy health concerns panel:-:Pt:^Patient:-


name: PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0


name: PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0


name: PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0


name: PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - social motivations for all smokers - version 1.0


name: PROMIS item bank - smoking - social motivations for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - upper extremity - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0


name: PROMIS item bank - upper extremity - version 2.0


name: PROMIS pediatric depressive symptoms - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric item bank - anxiety - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - anxiety - version 2.0


name: PROMIS pediatric item bank - asthma impact - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - asthma impact - version 2.0


name: PROMIS pediatric item bank - depressive symptoms - version 2.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - depressive symptoms - version 2.0


name: PROMIS pediatric item bank - fatigue - version 2.0


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0


name: Information source for rumor related to public health emergency:Find:Pt:^Event:Nom


name: Number of residence renovations:Num:Pt:^Patient:Ord


name: Opioid risk tool panel:-:Pt:^Patient:-:ORT


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: Public health emergency budget source:Type:Pt:^Event:Nom


name: Portable medical order form:Find:Pt:{Setting}:Doc:{Role}


name: Physical therapy plan of care panel:-:Pt:^Patient:-


name: PROMIS mobility - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS parent proxy anxiety - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy asthma impact - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy depressive symptoms - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy fatigue - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS pediatric item bank - fatigue - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - meaning and purpose - version 1.0


name: PROMIS pediatric item bank - meaning and purpose - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - pain behavior - version 1.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - pain behavior - version 1.0


name: PROMIS pediatric item bank - physical activity - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - physical activity - version 1.0


name: PROMIS pediatric item bank - physical stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - physical stress experiences - version 1.0


name: PROMIS pediatric item bank - positive affect - version 1.0


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: {28 (ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack [Symdeko (50 MG / 75 MG; 75 MG)]


name: Substance with acetylserotonin-O-methyltransferase inhibitor mechanism of action (substance)


name: Substance with glucagon-like peptide 2 receptor agonist mechanism of action (substance)


name: Glucagon-like peptide 2 receptor agonist (disposition)


name: Accuracy of information from source:Find:Pt:^Event:Ord


name: Action taken based on risk assessment meeting:Find:Pt:^Event:Nom


name: Action taken based on watch record:Find:Pt:^Event:Nom


name: Biophysical agent plan to use:Prid:Pt:^Patient:Nom


name: Blood group Ag & Hemoglobin S inferred phenotype panel:-:Pt:Bld/Tiss^Donor:-:Molgen


name: Blood group Ag & Hemoglobin S inferred phenotype panel:-:Pt:Bld/Tiss:-:Molgen


name: Emergency operations center activation level:Type:Pt:^Event:Ord


name: Finger chase - left:Score:Pt:^Patient:Ord


name: Finger chase - right:Score:Pt:^Patient:Ord


name: Cardiac drugs that increase blood pressure


name: Information communication technology description:Find:Pt:{Device}:Nom


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0


name: Time range until next menstrual period:Time:Pt:^Patient:Ord


name: PROMIS parent proxy item bank - anxiety - version 2.0


name: PROMIS parent proxy item bank - anxiety - version 2.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - asthma impact - version 2.0


name: PROMIS parent proxy item bank - asthma impact - version 2.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - depressive symptoms - version 2.0


name: PROMIS parent proxy item bank - depressive symptoms - version 2.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - meaning purpose - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - meaning purpose - version 1.0


name: PROMIS parent proxy item bank - pain behavior - version 1.0


name: PROMIS parent proxy item bank - pain behavior - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS pediatric item bank - psychological stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - psychological stress experiences - version 1.0


name: PROMIS pediatric item bank - strength impact - version 1.0


name: PROMIS pediatric item bank - strength impact - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric meaning and purpose - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric pain behavior - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric physical activity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric item bank - positive affect - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: Volunteer contact information panel:-:Pt:Volunteer:-


name: PROMIS parent proxy item bank - positive affect - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - positive affect - version 1.0


name: Substance with alkaline phosphatase inhibitor mechanism of action (substance)


name: Alkaline phosphatase inhibitor (disposition)


name: Substance with cytochrome P450 inhibitor mechanism of action (substance)


name: Interferon gamma inhibitor (disposition)


name: Substance with interferon gamma inhibitor mechanism of action (substance)


name: little c Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: C Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little c Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Source of population allelic frequency data:Type:Pt:^Population:Nom


name: Treadmill angina:Presence or Identity:Duration of the study:^Patient:Nominal


name: PROMIS parent proxy item bank - physical activity - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - physical activity - version 1.0


name: PROMIS parent proxy item bank - physical stress experiences - version 1.0


name: PROMIS parent proxy item bank - physical stress experiences - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - psychological stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - psychological stress experiences - version 1.0


name: PROMIS parent proxy item bank - strength impact - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - strength impact - version 1.0


name: PROMIS pediatric positive affect - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric psychological stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - pain behavior 8a - version 1.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric short form - pain behavior 8a - version 1.0


name: PROMIS pediatric physical stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: Age when first fed formula:Time:Pt:^Patient:Qn


name: Age when first fed something other than breast milk or formula


name: Age when first fed something other than breast milk or formula:Time:Pt:^Patient:Qn


name: Age when first injected non-prescription drug:Time:Pt:^Patient:Qn


name: Age when first injected non-prescription drug


name: Age when first used cocaine or crack:Time:Pt:^Patient:Qn


name: Intent of carbon monoxide exposure:Find:Pt:^Patient:Nom


name: Is your baby living with you:Find:Pt:^Patient:Ord


name: Emergency response improvement activity:Type:Pt:^Event:Nom


name: Emergency response plan objective:Find:Pt:^Event:Nom


name: Emergency response plan success analysis


name: Information communication technology description


name: Information communication technology name


name: Information communication technology name:ID:Pt:{Device}:Nom


name: Information communication technology type:Type:Pt:{Device}:Nom


name: Information communication technology type


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0


name: Received healthcare in U.S. but outside resident state:Loc:Pt:^Patient:Nom


name: Reliability of information source:Find:Pt:^Event:Ord


name: Spinal muscular atrophy newborn screening comment-discussion


name: Spinal muscular atrophy newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Spinal muscular atrophy newborn screening panel


name: Spinal muscular atrophy newborn screening panel:-:Pt:Bld.dot:-


name: PROMIS pediatric short form - pain behavior 8a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PEDS


name: PROMIS pediatric strength impact - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS physical function - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS self-efficacy for managing emotions - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS self-efficacy for managing medications and treatments - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Alpha1 proteinase inhibitor (disposition)


name: Age when first used heroin:Time:Pt:^Patient:Qn


name: Age when first used marijuana:Time:Pt:^Patient:Qn


name: Age when stopped smoking cigarettes completely


name: Age when stopped smoking cigarettes completely:Time:Pt:^Patient:Qn


name: Discharged from the U.S. Armed Forces:Find:Pt:^Patient:Ord


name: PROMIS parent proxy pain behavior - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy physical activity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy physical stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy meaning purpose - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: prothrombin activity actual/normal in platelet poor plasma by coagulation assay (lab test)


name: {1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack


name: Post-discharge provider name in Provider


name: unidentified cells/100 leukocytes in cerebral spinal fluid by manual count (lab test)


name: HIV reverse transcriptase susceptibility panel by Genotype method (lab test)


name: mononuclear cells/100 leukocytes in cerebral spinal fluid (lab test)


name: Unique bar code number of Initial sample


name: Sample quality of Dried blood spot (lab test)


name: mesothelial cells/100 leukocytes in cerebral spinal fluid (lab test)


name: Noninvasive prenatal fetal 18 and 21 aneuploidy panel, Plasma cell-free DNA by Sequencing


name: Bilateral bidirectional superior cavopulmonary anastomoses


name: HIV nonnucleoside reverse transcriptase susceptibility panel by Genotype method (lab test)


name: HIV nucleoside reverse transcriptase susceptibility panel by Genotype method (lab test)


name: Specific gravity of Urine by Automated test strip (lab test)


name: Serotonin receptor agonist (disposition)


name: Cross-Linking and Immunoprecipitation Followed by Deep Sequencing


name: Amputation of bilateral feet (procedure)


name: Dihydrofolate reductase inhibitor (disposition)


name: mononuclear cells/100 leukocytes in cerebral spinal fluid by manual count


name: Substance with neprilysin inhibitor mechanism of action (substance)


name: Blood gas analyses base excess in capillary blood by calculation


name: mesothelial cells/100 leukocytes in cerebral spinal fluid by manual count


name: Eosinophils/100 leukocytes in Urine sediment by Manual count


name: Views + Danelius Miller:Find:Pt:Lower extremity>Hip:Doc:XR


name: Transnasal humidified rapid-insufflation ventilatory exchange


name: I have trouble concentrating in the past 7D


name: Days in therapeutic INR range/Days INR result determined


name: Lidocaine Hydrochloride;Cream, Multi Ingredient 5%; NA Topical application Kit


name: {5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 7.1 - 7.5 kg]


name: {8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 11.6 - 12.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 11.1 - 11.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 10.6 - 11.0 kg]


name: {7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 10.1 - 10.5 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 9.6 - 10.0 kg]


name: {9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 13.1 - 13.5 kg]


name: {2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 2.6 - 3.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 4.6 - 5.0 kg]


name: {3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 4.1 - 4.5 kg]


name: Human reference sequence assembly version


name: Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel, Plasma cell-free DNA by Sequencing


name: HIV protease gene mutations by Genotype method (lab test)


name: HIV protease gene mutations by Phenotype method


name: HIV susceptibility panel by Genotype method (lab test)


name: microdeletion syndromes in blood or tissue by FISH


name: {28 (alpelisib 200 MG Oral Tablet [Piqray]) } Pack [Piqray 200 MG Daily Dose]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 12.6 - 13.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 6.6 - 7.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 6.1 - 6.5 kg]


name: {4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 5.6 - 6.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 5.1 - 5.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 9.1 - 9.5 kg]


name: {6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 8.6 - 9.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 8.1 - 8.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 7.6 - 8.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 12.1 - 12.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 1 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 3.1 - 3.5 kg]


name: {56 (alpelisib 150 MG Oral Tablet [Piqray]) } Pack [Piqray 300 MG Daily Dose]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 3.6 - 4.0 kg]


name: Lower oesophageal sphincter magnetic augmentation


name: Patent ductus arteriosus stent placement


name: Nuclear magnetic resonance imaging pancreas


name: International cooperative ataxia rating scale


name: Therapeutic tumor infiltrating lymphocytes (procedure)


name: Magnetic resonance proton density fat fraction measurement


name: coagulation factor X activity actual/normal in platelet poor plasma by chromogenic method


name: Clinical Proteomic Tumor Analysis Consortium


name: CDISC SEND Rad/Nuc Agent Source Response Terminology


name: Radiological/Nuclear Challenge Agent Source Type


name: CDISC SEND Biological Challenge Agent Category Response Terminology


name: Fractional oxyhemoglobin in Arterial blood (lab test)


name: HIV integrase inhibitor susceptibility panel by Genotype method (lab test)


name: HIV integrase inhibitor susceptibility panel by Phenotype method (lab test)


name: {39 (dexamethasone 1.5 MG Oral Tablet) } Pack [Dxevo 11 Day Taper]


name: {9 (cladribine 10 MG Oral Tablet) } Pack


name: {8 (cladribine 10 MG Oral Tablet) } Pack


name: {8 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 8 Tablet Pack]


name: {7 (cladribine 10 MG Oral Tablet) } Pack


name: {7 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 7 Tablet Pack]


name: {6 (cladribine 10 MG Oral Tablet) } Pack


name: {6 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 6 Tablet Pack]


name: {5 (cladribine 10 MG Oral Tablet) } Pack


name: {5 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 5 Tablet Pack]


name: {4 (cladribine 10 MG Oral Tablet) } Pack


name: {4 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 4 Tablet Pack]


name: {2 (cladribine 10 MG Oral Tablet) } Pack


name: {2 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 2 Tablet Pack]


name: CDISC SEND Study Report Status Response Terminology


name: {10 (cladribine 10 MG Oral Tablet) } Pack


name: {10 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 10 Tablet Pack]


name: {12 (siponimod 0.25 MG Oral Tablet) } Pack


name: {2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe [Skyrizi]) } Pack [Skyrizi 150 MG Dose Syringe Pack]


name: {2 (thyrotropin alfa 1.1 MG Injection) } Pack


name: Compression Therapy for Neuropathy Prevention


name: Challenge Agent Treatment Efficacy Study


name: Radiological/Nuclear Agent Ionizing Radiation Type


name: CDISC SEND Rad/Nuc Agent Ionizing Radiation Type Response Terminology


name: Cladribine 10 MG Oral Tablet [Mavenclad], Includes the 4, 5, 6, 7, 8, 9 & Mavenclad 10 Tablet Pack


name: CDISC SEND Challenge Agent Category Response Terminology


name: Threonine to Creatinine Ratio Measurement


name: Hemoglobin H Inclusion Bodies Measurement


name: Unique bar code number of Current sample


name: rnax perform urinary catheter care (treatment)


name: {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]) } Pack [Evenity 210 MG Dose]


name: protirelin 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL LOTION [Aveeno Absolutely Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 12 mg in 1 mL TOPICAL LOTION [WL-AAJ-Z-W-508 (Kopari 50ml)]


name: ZINC OXIDE 33.18 g in 177 mL TOPICAL LOTION [365 Everyday Value]


name: ZINC OXIDE 8.25 g in 44 mL TOPICAL LOTION [365 Everyday Value]


name: Florfenicol 1 g in 1 g NOT APPLICABLE POWDER


name: almond oil/silicon,colloidal/butylated hydroxytoluene ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: gelatin sponge,absorbable TOPICAL SYRINGE (EA)


name: TITANIUM DIOXIDE 78 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL CREAM [Lilikoi Mineral Defense Moisturizer SPF 33]


name: ZINC OXIDE 70 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL LOTION [Lilikoi Light Defense Face Primer SPF 23]


name: OCTINOXATE 83 mg in 1 mL / ZINC OXIDE 66 mg in 1 mL TOPICAL CREAM [SEKKISEI TREATMENT BB 00]


name: ENSULIZOLE 3 g in 100 mL TOPICAL LIQUID [FULL SPECTRUM MATTE AMBITION SKIN PRIMER SPF 20]


name: {21 (dexamethasone 1.5 MG Oral Tablet) } Pack [HiDex 6-Day Taper]


name: {27 (dexamethasone 1.5 MG Oral Tablet) } Pack [TaperDex 7-Day Taper]


name: BAG,BEDSIDE,MOVEEN 2000ML COLOPLAST #21346


name: BANDAGE TUBULAR ELASTIC 4.5IN X 11YD GLG10


name: TUBE FEEDING SET,EXTENSION ENFIT#0141-24


name: DRESSING,PURACOL PLUS 1IN X 8IN MSC861X8


name: DRESSING,AQUACEL AG SURGICAL 9CM X 25CM C#412011


name: AVOBENZONE 3 g in 100 g / OCTISALATE 2 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL LOTION [Gold Bond Ultimate 5-in-1 Face]


name: Solox Gel Silver Antimicrobial Topical Wound Gel


name: Accu-Chek Aviva Plus Blood Glucose Meter Kit


name: Gel, Multi Ingredient Topical application Gel/Jelly [COLLATYL]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Toleriane Double Repair Moisturizer UV SPF 30]


name: SPOTLESS Regimen for Acne, Blemishes and Breakouts KIT


name: TITANIUM DIOXIDE 0.03 g in 1 mL / ZINC OXIDE 0.14 g in 1 mL TOPICAL LOTION [UNBLEMISH Shine Free]


name: ZINC OXIDE 18 g in 100 g TOPICAL LOTION [BABY MINERAL SUNSCREEN ROLL-ON SPF-50]


name: zinc oxide 7 g in 100.0 mL / TITANIUM DIOXIDE 3 g in 100.0 mL TOPICAL CREAM [DermaDoctor DD Eye SPF30]


name: GoodSense 3-Bevel 31G 3/16 inch Pen Needle


name: GoodSense 3-Bevel 31G 5/16 inch Pen Needle


name: GoodSense 3-Bevel 32G 1/4 inch Pen Needle


name: GoodSense 3-Bevel 32G 5/32 inch Pen Needle


name: GoodSense 31G 3/16 inch Safety Pen Needle


name: Nutricia KetoCal 2.5:1 Enteral Suspension (Vanilla)


name: Hypochlorous Acid 0.0085% Topical application Gel/Jelly [ZENOPTIQ]


name: Lubricant Topical application Gel/Jelly [AQUA LUBE NATURAL]


name: Medical Food Oral Powder for Suspension [TYR SPHERE 20]


name: Oatmeal, Gum Fraction 1% Topical application Cream [ECZEMA RELIEF]


name: Hypochlorous Acid 0.0085% Topical application Gel/Jelly


name: Hypochlorous Acid 0.012% Topical application Solution


name: Placental Tissue Human Topical application Sheet


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Pin Point)


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Rounded)


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Soft Angled)


name: {1 (acetaminophen 650 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG Granules for Oral Solution) / 1 (acetaminophen 650 MG / dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG Powder for Oral Solution) } Pack


name: Hypochlorous Acid 0.01% Topical application Solution [ZENOPTIQ]


name: TIAMULIN FUMARATE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 6.9 g in 100 g / OCTISALATE 3 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL LOTION


name: {3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack


name: {3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 84 MG Dose Kit]


name: {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack


name: {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 56 MG Dose Kit]


name: OCTINOXATE 3 g in 100 mL TOPICAL LIQUID [Covergirl Outlast Active Foundation SPF 20]


name: ZINC OXIDE 7 g in 100 g / TITANIUM DIOXIDE 5 g in 100 g TOPICAL LOTION [BABY MINERAL SUNSCREEN ROLL-ON SPF-30]


name: TITANIUM DIOXIDE 17.6 mg in 1 mL TOPICAL EMULSION [LESSENTIEL NATURAL GLOW FOUNDATION 16H WEAR WITH SUNSCREEN BROAD SPECTRUM SPF 20 00C PORCELAINE ROSE/PORCELAIN COOL]


name: TITANIUM DIOXIDE 17.6 mg in 1 mL TOPICAL EMULSION [PLESSENTIEL NATURAL GLOW FOUNDATION 16H WEAR WITH SUNSCREEN BROAD SPECTRUM SPF 20 00N PORCELAINE/PORCELAIN]


name: TITANIUM DIOXIDE 40 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [VERTRA Premium Suncare SPF 30]


name: TITANIUM DIOXIDE 50 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL LOTION [VERTRA Premium Suncare SPF 50]


name: TITANIUM DIOXIDE 17.6 mg in 1 mL TOPICAL EMULSION [LESSENTIEL NATURAL GLOW FOUNDATION 16H WEAR WITH SUNSCREEN BROAD SPECTRUM SPF 20 04W MOYEN DORE/MEDIUM WARM]


name: {1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack


name: AMINOPENTAMIDE SULFATE 1 g in 1 g NOT APPLICABLE POWDER


name: Adenosine 0.02 g in 50 mL TOPICAL CREAM [CONJU Princess Lifting]


name: DOXYCYCLINE 1 kg in 1 kg NOT APPLICABLE POWDER


name: TOCERANIB PHOSPHATE 1 g in 1 g NOT APPLICABLE POWDER


name: TRIMEPRAZINE TARTRATE 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 7.6 g in 100 g / ZINC OXIDE 5.1 g in 100 g TOPICAL CREAM [TRACELESS TOUCH FOUNDATION BROAD SPECTRUM SPF 45 REFILL CUSHION COMPACT]


name: ZINC OXIDE 220 mg in 1 mL TOPICAL OIL [ACTIVE ARGAN 365 SPF 30 BROAD SPECTRUM ACTIVATED ARGAN COMPLEX]


name: Adenosine 0.01 g in 25 mL TOPICAL PATCH [CONGJU PRINCESS LIFTING MASK SHEET]


name: Dimethicone 2.5 g in 50 mL TOPICAL GEL [CONJU PRINCESS MOISTURE]


name: Dimethicone 3.6 g in 120 mL TOPICAL LIQUID [CONJU PRINCESS RICH ESSENCE]


name: Mineral Oil 72.27 g in 100 mL TOPICAL GEL [CONJU PRINCESS CLEANSING BALM]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [CONGJU PRINCESS EYE AND NECK]


name: DIETHYLSTILBESTROL 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / TITANIUM DIOXIDE 0.49 g in 100 mL / OXYBENZONE 3.5 g in 100 mL TOPICAL LIQUID [miracle worker anti-aging foundation spf 30]


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM]


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT PEPTIDE SERUM]


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT HYALURONIC SERUM]


name: Niacinamide 0.6 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT 24K GOLD SERUM]


name: Niacinamide 0.6 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT BTX COLLAGEN SERUM]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Lilikoi Mineral Defense Sport Sunscreen SPF 30]


name: Compound HIPAA Research Authorization and Informed Consent for Research


name: jurisdictional specified controlled unclassified information policy


name: personal non-sensitive information policy


name: personal limited data set information policy


name: personal de-identified information policy


name: organizational uncontrolled unclassified information policy


name: organizational specified controlled unclassified information policy


name: organizational public information policy


name: organizational non-sensitive information policy


name: organizational limited data set information policy


name: organizational de-identified informati)on policy


name: organizational basic controlled unclassified information policy


name: jurisdictional uncontrolled unclassified information policy


name: jurisdictional public information policy


name: jurisdictional non-sensitive information policy


name: jurisdictional de-identified information policy


name: jurisdictional controlled unclassified information policy


name: Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes


name: HIPAA Authorization for Disclosure for Research Consent Directive


name: opt-out of personal information or effect sharing via a registry or repository


name: opt-out of personal information or effect collection in a registry or repository


name: opt-in to personal information or effect sharing via a registry or repository


name: opt-in to personal information or effect collection in a registry or repository


name: Foundational Model of Anatomy Ontology, 4_15


name: CPTAC Environmental/Occupational Exposure Codelist


name: Specify Site if Documented Distant Metastasis


name: Specify Type of Testing and Results if Yes


name: High Sensitivity C-Reactive Protein Measurement


name: Number of Lymph Nodes Positive for Tumor by IHC Staining Only


name: Number of Lymph Nodes Positive for Tumor by H&E


name: Viral Envelope Glycoprotein Purification


name: What is the First Presenting Symptom Related to Disease


name: Temporally-Feathered Intensity-Modulated Radiation Therapy


name: Use Phone Less Often than Would Like Due to Hearing Problem


name: Avoid Groups of People Due to Hearing Problem


name: Difficulty Attending Party Due to Hearing Problem


name: Feel Stupid or Dumb Due to Hearing Problem


name: Visit People Less Often than Like Due to Hearing Problem


name: Go Shopping Less Often than Like Due to Hearing Problem


name: Upset by Problem or Difficulty with Hearing


name: Talk to Family Members Less Often than Like Due to Hearing Problem


name: Listen to TV or Radio Less Often than Like Due to Hearing Problem


name: Feel Uncomfortable when Talking with Friends Due to Hearing Problem


name: Feel Left Out When with a Group of Friends Due to Hearing Problem


name: Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem


name: Difficulty in Movies or Theater Due to Hearing Problem


name: Multi-detector Computed Tomography Angiography


name: Civilian Health and Medical Program of the Department of Veterans Affairs


name: Hearing Handicap Inventory Screening Questionnaire for Adults


name: Did Patient Follow Through with Referral


name: What is the Hormonal Contraceptive Use Status


name: Age When Started using Smokeless Tobacco after Regular Use


name: Is there a First Degree Family History of Primary Brain Tumor


name: Is there a First Degree Family History of Thyroid Cancer


name: Boston University-Boston Medical Center Cancer Center


name: Brown University Oncology Research Group


name: How Often Took Retroviral Agents Past 6 Months


name: Fluorine F 18-Active Site Inhibited Factor VIIa


name: Nanoscale Coordination Polymer Nanoparticles CPI-100


name: CPTAC Bladder Urothelial Carcinoma Baseline Form


name: CPTAC Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma Baseline Form


name: CPTAC Esophageal Carcinoma Baseline Form


name: CPTAC Liver Hepatocellular Carcinoma Baseline Form


name: CPTAC Prostate Adenocarcinoma Baseline Form


name: CPTAC Stomach Adenocarcinoma Baseline Form


name: Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate


name: Emtricitabine/ Tenofovir Alafenamide Fumarate


name: Emtricitabine/ Rilpivirine/ Tenofovir Alafenamide Fumarate


name: Illness is Financial Hardship for My Family and Me


name: Pediatric Quality of Life Brain Tumor Module Version 1.0


name: CDISC Questionnaire PHQ-2 Test Name Terminology


name: CDISC Questionnaire PHQ-2 Test Code Terminology


name: PHQ-2 - Little Interest or Pleasure in Doing Things


name: PHQ-2 - Feeling Down, Depressed or Hopeless


name: Maraba Oncolytic Virus Expressing Mutant HPV E6/E7


name: Behavioral Measures For Treating Sleep Disordered Breathing


name: Cognitive behavioral therapy for insomnia


name: Glioma, Glioblastoma & Astrocytoma Surgery


name: Intestinal Rehabilitation and Transplant


name: Lower Gastrointestinal Therapeutic Surgical Procedure


name: Minimally Invasive Joint Replacement Surgery


name: Physical Therapy for Orthopedics and Sports Medicine


name: Scoliosis and Kyphosis Deformity Correction


name: Subfascial Endoscopic Perforator Surgery


name: Therapeutic Upper Gastrointestinal Procedures


name: Transthoracic Myocardial Laser Revascularization


name: Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY)


name: Recombinant Bovine Basic Fibroblast Growth Factor


name: Protein Arginine Methyltransferase 5 Inhibitor PF-06939999


name: Dihydroorotate Dehydrogenase Inhibitor AG-636


name: CDISC ADaM Geriatric Depression Scale Short Form Questionnaire Parameter Code Terminology


name: CDISC ADaM Geriatric Depression Scale Short Form Questionnaire Parameter Name Terminology


name: CDISC SEND Challenge Agent Parameter Code Terminology


name: CDISC SEND Challenge Agent Parameter Long Name Terminology


name: CDISC SEND Age Estimation Method Response Terminology


name: CDISC SEND Restraint Mode Response Terminology


name: CDISC SEND Sexual Maturity Status Response Terminology


name: Transplant Registry Unified Management Program


name: 7 Lead Placement Standard for Non-Human Subjects


name: Extended Release Capsule, Hard Dosage Form


name: Extended Release Capsule, Softgel Dosage Form


name: Monoclonal Protein Spike Region Identification


name: Soluble Interleukin 2 Receptor Measurement


name: Direct Bilirubin to Bilirubin Ratio Measurement


name: Glycated Albumin to Albumin Ratio Measurement


name: Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement


name: Sezary Cells to Leukocytes Ratio Measurement


name: Fluorescent Antibody Virus Neutralization Assay


name: Multiplex Real-time Polymerase Chain Reaction Assay


name: N-acetylaspartate and N-acetyl-aspartylglutamate Measurement


name: Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement


name: Creatine and Phosphocreatine Measurement


name: Glycerophosphorylcholine and Phosphorylcholine Measurement


name: IRANO Okada 2015 Oncology Response Criteria


name: Volume of Distribution Observed for Unbound Drug


name: Volume of Distribution Predicted for Unbound Drug


name: Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug


name: Estimated Next Menstrual Period Start Date


name: Master Bank or Seed Stock Immediate Supplier


name: Biological Agent Nucleotide Sequence Location


name: Radiological/Nuclear Agent Irradiation Source Beam Strength


name: Efficacy Study With Pre-Exposure Prophylaxis


name: Efficacy Study With Post-Exposure Prophylaxis


name: Efficacy Study With Post-Exposure Radiomitigation


name: Factor for Toxicological Dose Descriptor


name: High-Dose-Rate Vaginal Cuff Brachytherapy


name: Low-Dose-Rate Vaginal Cuff Brachytherapy


name: Months Since Completion of Primary Therapy


name: Physician's Global Assessment Scale of Epidermal Chronic Graft versus Host Disease


name: Lyophilisate and Solvent for Emulsion for Injection


name: Effervescent Powder and Powder for Oral Suspension


name: Green Tea/Licorice Extract-based Antioxidant Solution


name: Whey Protein Isolate-based Nutritional Supplement


name: CPTAC Brain Lower Grade Glioma Baseline Form


name: Aspartate Aminotransferase to Creatine Kinase Ratio Measurement


name: RANO Ellingson 2017 Oncology Response Criteria


name: Transcribe Data into CDR and Record the Following


name: Recombinant human glutamic acid decarboxylase


name: ZONISAMIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ETHAMBUTOL HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 192 mg in 1 g TOPICAL STICK [Baby Bum Mineral SPF50 Sunscreen]


name: DIETHYLTOLUAMIDE 10 g in 100 mL TOPICAL LIQUID [MOSQUITO BUG OFF]


name: GLYCERIN 8 g in 100 mL TOPICAL LIQUID [AMULDY S]


name: HOMOSALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / ZINC OXIDE 150 mg in 1 g TOPICAL STICK [Equate Sunscreen Mineral Based KIDS Broad Spectrum spf 50]


name: OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 6 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL TOPICAL CREAM [Olay Regenerist Micro-Sculpting Anti-Aging Moisturize Broad Spectrum SPF 30]


name: Titanium Dioxide 1.63 g in 15 g / Octinoxate 1.05 g in 15 g / Octisalate 0.45 g in 15 g TOPICAL POWDER [GALAXYBORN SATIN CUSHION NO 23]


name: Titanium Dioxide 1.70 g in 15 g / Octinoxate 1.05 g in 15 g / Octisalate 0.45 g in 15 g TOPICAL POWDER [GALAXYBORN SATIN CUSHION NO 21]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Equate Sunscreen SPF 50 SPORT Broad Spectrum]


name: Pro Comfort Adult Inhaler Spacer Chamber


name: Pro Comfort Child Inhaler Spacer Chamber


name: EnovaRX - Cyclobenzaprine Hydrochloride 2% in Microderm External Cream Compounding Kit


name: EnovaRX - Diclofenac Sodium 2.5% in Microderm External Cream Compounding Kit


name: Collagen, Bovine/Silver Oxide 1% Topical application Gel/Jelly


name: PYRIDOSTIGMINE BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [EQUATE Sunscreen SPORT Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate-Sunscreen Broad Spectrum SPF 50 ULTRA]


name: ENSULIZOLE 3 g in 100 mL TOPICAL LIQUID [Covergirl TruBlend Base Business Everyday Defense Primer SPF 20]


name: ALUMINUM CHLORIDE 15 g in 100 g TOPICAL LIQUID [Dr Sweat]


name: OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P100]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [EQUATE Sunscreen BABY Broad Spectrum SPF 50]


name: TITANIUM DIOXIDE 17.5 mg in 1 mL / OCTINOXATE 30 mg in 1 mL TOPICAL CREAM [TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P300]


name: Maltodextrin/Starch, Corn Oral Powder [THICK & EASY]


name: Exquisite HRT Cream Base for Compounding


name: Electrolytes Oral Solution [LEADER ELECTROLYTE]


name: Ointment, Multi Ingredient Topical application Ointment [LIP CARE]


name: OMEPRAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: {39 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: TRACH STOMA PROTECTOR,FOAM 2IN X 2.5IN LUMINAUD #63024


name: TRACH TUBE,SZ 7.5 BIVONA TTS SMITHS #670175


name: CATHERIZATION SET,FOLEY W/O CATH RELIAMED #ZRCIT10CC


name: CATHETER,FOLEY SILICONE DOVER 16FR 5ML COVIDIEN #605163IC


name: CATHETER,SUCTION,12FR KIT CARDINAL HEALTH #ZRSCK12


name: CHLOROXYLENOL 0.3 g in 100 mL TOPICAL LIQUID [GLOBAL HOME CARE 19OZ LEMON ANTIBACTERIAL DISH DETERGENT]


name: SET,INFUSION AUTOSOFT XC TANDEM #1001683


name: KIT PREP OF TECHNETUM TC-99 EXAMETAZIME INJ


name: KIT PREP OF TECHNETUM TC-99 MEBROFENIN INJ


name: Silicone Topical application Gel/Jelly [SCARSILK GEL]


name: camphor / lidocaine / menthol / methyl salicylate


name: ZINC OXIDE 21 g in 100 g TOPICAL STICK [Sunnyscreen SPF 50 Stick]


name: DOXYCYCLINE HYCLATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: OCTINOXATE 72 mg in 1 mL / TITANIUM DIOXIDE 26.736 mg in 1 mL TOPICAL CREAM [ACTIBEAU Camellia Floral Calming Sunscreen]


name: TITANIUM DIOXIDE 10 g in 100 mL / ZINC OXIDE 12 g in 100 mL TOPICAL SPRAY [Sunnyscreen SPF 50]


name: ZINC OXIDE 109.52 mg in 1 mL / TITANIUM DIOXIDE 48.187 mg in 1 mL TOPICAL CREAM [ACTIBEAU Camellia Natural Mineral UV Defense Sunscreen]


name: CARBAZOCHROME 1 g in 1 g NOT APPLICABLE POWDER


name: multivitamin with minerals combination no.65


name: water for injection (PEG-400, NADA, lysine)


name: lancing device, vacuum/lancets MISCELL COMBINATION PACKAGE (EA)


name: emollient combination no.112 TOPICAL CREAM (GRAM)


name: emollient combination no.113 TOPICAL CREAM (GRAM)


name: lollipop base no.232 MISCELL POWDER (GRAM)


name: suppository base no.231 MISCELL PELLET (GRAM)


name: suppository base no.234 MISCELL PELLET (GRAM)


name: urinary bag/catheter 12 Fr-8" MISCELL COMBINATION PACKAGE (EA)


name: lollipop base no.233 MISCELL POWDER (GRAM)


name: ALLANTOIN 0.05 g in 100 g TOPICAL LIQUID [Kenaf wet wipe kids]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL LOTION [BOTANIC TWENTY RECHARGING]


name: ADENOSINE 0.04 g in 150 mL / NIACINAMIDE 2 g in 150 mL TOPICAL CREAM [BOTANIC TWENTY HYPERCARE NOURISHING]


name: ADENOSINE 0.04 g in 50 mL / NIACINAMIDE 2 g in 50 mL TOPICAL CREAM [BOTANIC TWENTY LIGHT WATERY]


name: OCTINOXATE 60 mg in 1 mL / ZINC OXIDE 20 mg in 1 mL TOPICAL CREAM [Sudden Change Derma Renewal Complex]


name: {9 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 9 Tablet Pack]


name: DIMETHICONE 4 mg in 1 mL TOPICAL CREAM [AFTER CARE]


name: ERYTHROMYCIN ETHYLSUCCINATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: HOMOSALATE 10 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [3-in-1 Face Moisturizer Broad Spectrum SPF 20]


name: almond oil/silicic acid/butylated hydroxytoluene ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: hypochlorous,hydrochlor acid/sodhypochlor/sodmagfluo/e.water 0.0085 % TOPICAL GEL WITH PUMP (ML)


name: hypochlorous,hydrochlor acid/sodhypochlor/sodmagfluo/e.water 0.02 % TOPICAL SPRAY GEL (ML)


name: sodium/chloride/citrate 50 mEq-20 mEq-30 mEq ORAL POWDER IN PACKET (EA)


name: thiamine mononitrate (vit B1) 90 mg/scoop ORAL POWDER (GRAM)


name: ZINC OXIDE 60 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [JACKET SPF-50 Broad Spectrum Sunscreen]


name: ZINC OXIDE 80 mg in 1 g TOPICAL STICK [Sun Bum Signature SPF 30 Sunscreen Lip Balm]


name: {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe) } Pack


name: ZINC OXIDE 20.5 g in 100 g TOPICAL LOTION [NATURAL SUNSCREEN FOR KIDS/BABY SPF 40]


name: {12 (siponimod 0.25 MG Oral Tablet [Mayzent]) } Pack [Mayzent 2 MG Starter Pack]


name: Niacinamide 1.60 g in 80 mL / Adenosine 0.03 g in 80 mL TOPICAL SPRAY [RUBELLI WATER GLOW ESSENCE 80mL]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [Equate Ultra Light Sunscreen MIST SPF70]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL OIL [Sun Bum Premium SPF 15 Sunscreen Tanning]


name: HOMOSALATE 70 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL SPRAY [EQUATE Tanning Sunscreen Dry oil UVB Protection SPF10]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL SPRAY [Derma E Ultra Sheer Mineral Body Sunscreen Mist SPF 30]


name: OCTOCRYLENE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL SPRAY [Derma-E All Sport Performance Sunscreen SPF 50]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Derma-E All sport Performance Face Sunscreen SPF 30]


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL CREAM [INCELLDERM Cocktail Aqua BB]


name: Niacinamide 0.75 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [INCELLDERM ACTIVE]


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL SPRAY [INCELLDERM Vallatto Oi l Mist]


name: {2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe) } Pack


name: Ageratum yellow vein Sri Lanka betasatellite


name: Tomato leaf curl Philippine betasatellite


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Russian Edition


name: GoodSense 6-Bevel 32G 5/32 inch Pen Needle


name: GoodSense 6-Bevel 31G 3/16 inch Pen Needle


name: Accu-Chek Guide Me Blood Glucose Monitor Kit


name: Systane Lid Wipes Eyelid Cleansing Wipes


name: Nicotinamide Riboside Chloride Bulk powder


name: Articaine Hydrochloride and Epinephrine Bitartrate


name: Contour Next One Monitor Syst by Ascencia


name: Contour Next Glucose Test Strips by Ascensia


name: Contour Next EZ Monitor Syst by Ascensia


name: Contour Monitor Syst, Simple Pk by Ascensia


name: Contour Blood Glucose Test Strips by Ascensia


name: Lotion, Multi Ingredient Topical application Lotion [DAILY MOISTURIZING LOTION]


name: Cream, Multi Ingredient Topical application Cream [MOISTURIZING CREAM]


name: Valbenazine;Valbenazine 40 MG; 80 MG Oral Capsule


name: LAPATINIB 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Play Mineral Sunstick SPF-30]


name: Zinc Oxide 64 mg in 1 mL / Octinoxate 59 mg in 1 mL / Octisalate 38 mg in 1 mL / Oxybenzone 47 mg in 1 mL TOPICAL LOTION [Rugid Sunscreen]


name: ZINC OXIDE 176.7 mg in 1 g / OCTINOXATE 69.9 mg in 1 g CUTANEOUS CREAM [Noevir Raysela UV Shield Primer]


name: TITANIUM DIOXIDE 5 g in 100 mL / ZINC OXIDE 7 g in 100 mL TOPICAL LOTION [Play Mineral Sunscreen SPF-50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 37.5 mg in 1 g TOPICAL SPRAY [Sun Bum SPF 30 Premium Moisturizing Sunscreen]


name: AVOBENZONE 30 g in 1 L / HOMOSALATE 50 g in 1 L / OCTISALATE 30 g in 1 L / OCTOCRYLENE 100 g in 1 L TOPICAL LOTION [Sun Bum SPF 30 Premium Moisturizing Sunscreen]


name: AVOBENZONE 30 g in 1 L / HOMOSALATE 100 g in 1 L / OCTISALATE 50 g in 1 L / OCTOCRYLENE 100 g in 1 L TOPICAL LOTION [Sun Bum SPF 50 Premium Moisturizing Sunscreen]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 24 g in 100 mL TOPICAL LOTION [Play Mineral Broad Spectrum SPF 50]


name: ETHYLHEXYL TRIAZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 50 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / ECAMSULE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / BEMOTRIZINOL 40 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 30 mg in 1 mL TOPICAL LOTION [Kiehls Activated Sun Protector Sunscreen SPF 30 For Face and Body For All Skin Types]


name: DROMETRIZOLE TRISILOXANE 40 mg in 1 mL / ECAMSULE 120 mg in 1 mL / BEMOTRIZINOL 5 mg in 1 mL / TITANIUM DIOXIDE 40 mg in 1 mL / OCTINOXATE 67.5 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 5 mg in 1 mL TOPICAL CREAM [Kiehls Ultra Light Daily UV Defense CC SPF 50 Anti Pollution]


name: OCTINOXATE 7.5 g in 100 g / HOMOSALATE 6 g in 100 g / MERADIMATE 4 g in 100 g / OXYBENZONE 5 g in 100 g TOPICAL LIPSTICK [ALOE UP MEDICATED LIP ICE SUNSCREEN SPF 30]


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 14.5 g in 100 g / OXYBENZONE 5.9 g in 100 g TOPICAL CREAM [ALOE KOTE SPF 25]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTINOXATE 6 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [ALOE UP SUNSCREEN SPF 50]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 2.5 g in 100 g / OXYBENZONE 6 g in 100 g TOPICAL LIPSTICK [ALOE UP MEDICATED LIP BALM SPF 30]


name: AVOBENZONE 1 g in 100 mL / OCTISALATE 3 g in 100 mL / HOMOSALATE 1 g in 100 mL / OCTOCRYLENE 0.85 g in 100 mL TOPICAL SPRAY [ALOE UP LIGHT TANNING OIL SPF-6]


name: SIROLIMUS 1 g in 1 g NOT APPLICABLE POWDER


name: Niacinamide 0.70 g in 35 mL / Adenosine 0.01 g in 35 mL TOPICAL LIQUID [LECINQ PREBENONE SERUM]


name: DACTINOMYCIN 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 1.284 mg in 30 mL / ZINC OXIDE 0.864 mg in 30 mL TOPICAL CREAM [Dr.Jart Cicapair Tiger Grass Camo Drops]


name: OCTOCRYLENE 41.8 mg in 1 mL / ZINC OXIDE 104.5 mg in 1 mL TOPICAL LOTION [Blue Lizard Sport Sunscreen]


name: Octisalate 0.04 g in 1 mL / Homosalate 0.08 g in 1 mL / Avobenzone 0.03 g in 1 mL / Octocrylene 0.07 g in 1 mL / Octinoxate 0.02 g in 1 mL TOPICAL LOTION [VITAMIN E MOISTURE-PROTECT SPF 30 PA plus plus plus]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 5 g in 100 mL TOPICAL LOTION [MURAD - ACNE CONTROL - oil AND PORE CONTROL MATTIFIER SPF-45]


name: TITANIUM DIOXIDE 2.1 g in 50 g / ZINC OXIDE 3.5 g in 50 g / OCTINOXATE 3.75 g in 50 g TOPICAL CREAM [Carecella Velvet Cover BB Cream]


name: ASPARAGINASE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [Protetor Solar Grip Action FPS 40]


name: ZINC OXIDE 20 mg in 1 mL TOPICAL LOTION [Sun Guard]


name: Niacinamide 1.30 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [PAPA RECIPE EGGPLANT CLEARING]


name: Niacinamide 0.5 g in 25 g TOPICAL PATCH [PAPA RECIPE BOMBEE BRIGHTENING HONEY MASK PACK]


name: Adenosine 0.012 g in 30 mL TOPICAL LIQUID [MUSTUS NONI AMPOULE]


name: Octinoxate 3.50 g in 50 mL / Homosalate 1.50 g in 50 mL / Octisalate 1.50 g in 50 mL / Titanium Dioxide 0.74 g in 50 mL TOPICAL CREAM [PAPA RECIPE HONEY MOIST SUN ESSENCE]


name: GLYCERIN 1.131 g in 25 mL / Allantoin 0.025 g in 25 mL TOPICAL LIQUID [Ashwagandha Ferment Mask]


name: ZINC OXIDE 13 g in 100 mL TOPICAL LOTION [Zinc Screen Broad Spectrum Sunscreen SPF 40]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [BEAST HYDRATING FACE SPF-20]


name: Adenosine 0.008 g in 20 g TOPICAL PATCH [MUSTUS DAILY HARVEST SQUEEZE LIFT UP MASK PACK]


name: Niacinamide 0.4 g in 20 g TOPICAL PATCH [MUSTUS DAILY HARVEST SQUEEZE TONE UP MASK PACK]


name: METRONIDAZOLE BENZOATE 1 g in 1 g NOT APPLICABLE POWDER


name: CLARITHROMYCIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: frida mom Postpartum Recovery Essentials KIT


name: frida mom Labor and Delivery Plus Postpartum Recovery KIT


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Peach Mango]


name: ZINC OXIDE 145.7 mg in 1 mL TOPICAL LOTION [Chemical Free Sunscreen]


name: ZINC OXIDE 130 mg in 1 mL TOPICAL LOTION [TreeActiv Safflower Oleosomes Daily Natural Moisturizing Sunscreen Broad Spectrum SPF 30]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OXYBENZONE 30 mg in 1 mL TOPICAL CREAM [Daily Moisturizing SPF 15]


name: FIPRONIL 1 kg in 1 kg NOT APPLICABLE POWDER


name: Niacinamide 0.48 g in 24 mL / Adenosine 0.009 g in 24 mL TOPICAL PATCH [HI HANJI]


name: OCTOCRYLENE 41.8 mg in 1 mL / ZINC OXIDE 104.5 mg in 1 mL TOPICAL LOTION [Blue Lizard Active Sunscreen]


name: OCTINOXATE 67.4 mg in 1 g TOPICAL PASTE [SUGAR LIP TREATMENT SUNSCREEN SPF 15]


name: VORINOSTAT 1 g in 1 g NOT APPLICABLE POWDER


name: TIOPRONIN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL 1 kg in 1 kg NOT APPLICABLE POWDER


name: urinary bag/catheter 14 Fr-8" MISCELL COMBINATION PACKAGE (EA)


name: troche base no.235 MISCELL POWDER (GRAM)


name: nutritional tx, ketogenic,whey 2.8 gram-104 kcal/100 mL ORAL LIQUID (ML)


name: nutritional therapy for propionic acidemia with iron 60 gram-297 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria (PKU) no.68 15 gram-330 kcal/81 gram ORAL BAR


name: compound vehicle suspension sugar-free no.25 ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: compound vehicle suspension sugar-free no.24 ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: COMBINATION PACK, CAPSULE AND CAPSULE DR


name: parenteral amino acid 15 % combination no.6


name: nutritional therapy for phenylketonuria(PKU) no.72


name: compounding vehicle suspension sugar free no.25


name: compounding vehicle suspension sugar free no.24


name: Lombardy poplar pollen extract / white poplar pollen extract


name: CATHERIZATION SET,INTERMITTENT 16FR BARD #4A8116


name: MEDICINE DOSE CUP,GRADUATED,METRIC ONLY,30ML


name: TRACH TUBE,SZ 8 BIVONA TTS SMITHS #670180


name: CATHETER FOLEY 3-WAY 24FR 5ML BARD #0119L24


name: CATHETER,INTERMITTENT,GENTLECATH 14FR FEMALE #509007


name: DRESSING,MEPILEX BORDER AG 9.2IN X 9.2IN #382490


name: CENTRAL LINE DRESSING CHANGE KIT,DEROYAL #47-276


name: DRESSING,OPTIFOAM GENTLE BORDER 3IN X 3IN #MSC2133


name: ATPase-coupled calcium transmembrane transporter activity


name: intermembrane phosphatidylinositol transfer activity


name: ATPase-coupled potassium transmembrane transporter activity


name: ATPase-coupled manganese transmembrane transporter activity


name: ATPase-coupled intramembrane lipopolysaccharide transporter activity


name: intermembrane glycolipid transfer activity


name: intermembrane glycolipid transporter activity


name: positive regulation of decapentaplegic receptor signaling pathway


name: ATP-dependent sterol transmembrane transporter activity


name: ATP-dependent intramembrane glycolipid transporter activity


name: ATPase-coupled intramembrane glycolipid transporter activity


name: host-induced regulation of intestinal microbiota composition


name: modulation by symbiont of host autophagy


name: ATP-dependent phosphatidylcholine transporter activity


name: ATPase-coupled phosphatidylcholine transporter activity


name: ATP-dependent phosphatidylethanolamine transporter activity


name: ATPase-coupled phosphatidylethanolamine transporter activity


name: ATPase-coupled phosphatidylserine transporter activity


name: ATPase-dependent phosphatidylserine transporter activity


name: ATP-dependent ceramide transporter activity


name: ATPase-coupled ceramide transporter activity


name: intermembrane phosphatidylcholine transfer activity


name: intraciliary transport particle B binding


name: stress-induced homeostatically regulated protein degradation pathway


name: positive regulation of mitotic division septum assembly


name: ATPase-coupled phospholipid transporter activity


name: ATPase-dependent phospholipid transporter activity


name: intermembrane phosphatidylserine carrier activity


name: regulation of homeostatic synaptic scaling


name: intermembrane ceramide 1-phosphate transfer activity


name: intermembrane phosphatidylethanolamine transfer activity


name: regulation of xenobiotic transmembrane export


name: negative regulation of xenobiotic transmembrane export


name: positive regulation of xenobiotic transmembrane export


name: intermembrane phosphatidic acid transfer activity


name: RNA polymerase III general transcription initiation factor activity


name: RNA polymerase I general transcription initiation factor activity


name: epithelial cilium movement involved in extracellular fluid movement


name: respiratory gaseous exchange by respiratory system


name: ATPase-coupled bile acid transmembrane transporter activity


name: ATPase-coupled putrescine transmembrane transporter activity


name: ferric triacetylfusarinine C import into cell


name: 2'-deoxyguanosine DNA ADP-ribosyltransferase activity


name: ATPase-coupled lipid transmembrane transporter activity


name: ATPase-coupled sterol transmembrane transporter activity


name: regulation of cell population proliferation


name: host-mediated regulation of intestinal microbiota composition


name: basement membrane disassembly involved in semicircular canal fusion


name: GPI-mannose ethanolamine phosphate phosphodiesterase activity


name: compound eye pigment cell differentiation


name: transcription factor TFIIH holo complex binding


name: NuA4 histone acetyltransferase complex binding


name: PSII associated light-harvesting complex II binding


name: inhibitory MHC class Ib receptor activity


name: activating MHC class Ib receptor activity


name: HLA-E specific inhibitory MHC class Ib receptor activity


name: HLA-G specific inhibitory MHC class Ib receptor activity


name: regulation of capsule polysaccharide biosynthetic process


name: positive regulation of capsule polysaccharide biosynthetic process


name: regulation of vein smooth muscle contraction


name: positive regulation of vein smooth muscle contraction


name: negative regulation of vein smooth muscle contraction


name: regulation of taurine biosynthetic process


name: positive regulation of taurine biosynthetic process


name: regulation of programmed necrotic cell death


name: negative regulation of programmed necrotic cell death


name: positive regulation of programmed necrotic cell death


name: peptidyl-aspartic acid 3-dioxygenase activity


name: female germline stem cell symmetric division


name: regulation of protein localization to non-growing cell tip


name: negative regulation of protein localization to non-growing cell tip


name: regulation of DNA recombinase disassembly


name: negative regulation of DNA recombinase disassembly


name: fatty acid primary amide biosynthetic process


name: histone H3K37 methyltransferase activity


name: fatty acid primary amide metabolic process


name: fatty acid primary amide catabolic process


name: positive regulation of cardiac muscle cell contraction


name: negative regulation of cardiac muscle cell contraction


name: lectin-induced modified bacterial internalization


name: 4-hydroxyindole-3- carbonyl nitrile biosynthesis


name: indole-3-carbonyl nitrile 4-hydroxylase activity


name: regulation of exonucleolytic catabolism of deadenylated mRNA


name: spindle pole body-nuclear membrane anchor activity


name: regulation of imaginal disc-derived wing vein specification


name: positive regulation of imaginal disc-derived wing vein specification


name: negative regulation of imaginal disc-derived wing vein specification


name: positive regulation of animal organ morphogenesis


name: negative regulation of animal organ morphogenesis


name: regulation of lipid transporter activity


name: positive regulation of lipid transporter activity


name: negative regulation of lipid transporter activity


name: regulation of compound eye photoreceptor cell differentiation


name: positive regulation of compound eye photoreceptor cell differentiation


name: negative regulation of compound eye photoreceptor cell differentiation


name: positive regulation of very-low-density lipoprotein particle clearance


name: gamma-tubulin complex localization to nuclear side of mitotic spindle pole body


name: gamma-tubulin complex localization to cytoplasmic side of mitotic spindle pole body


name: positive regulation of myotube cell migration


name: negative regulation of myotube cell migration


name: regulation of imaginal disc-derived leg joint morphogenesis


name: positive regulation of imaginal disc-derived leg joint morphogenesis


name: negative regulation of imaginal disc-derived leg joint morphogenesis


name: protein maturation by nickel ion transfer


name: detection of cold stimulus involved in thermoception


name: positive regulation of torso signaling pathway


name: negative regulation of torso signaling pathway


name: regulation of focal adhesion disassembly


name: positive regulation of focal adhesion disassembly


name: negative regulation of focal adhesion disassembly


name: negative regulation of protein localization to chromatin


name: positive regulation of protein localization to chromatin


name: positive regulation of bile acid secretion


name: negative regulation of bile acid secretion


name: positive regulation of anther dehiscence


name: negative regulation of anther dehiscence


name: positive regulation of imaginal disc-derived wing size


name: methylcytosine to 5-glyceryl-methylcytosine dioxygenase activity


name: general transcription initiation factor activity


name: serotonin-gated cation-selective signaling pathway


name: anterograde axonal transport of neurotransmitter receptor complex


name: intracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential


name: intracellular cAMP-activated cation channel activity involved in regulation of postsynaptic membrane potential


name: protein catabolic process at postsynapse


name: regulation protein catabolic process at synapse


name: regulation protein catabolic process at presynapse


name: regulation protein catabolic process at postsynapse


name: regulation of cellular response to phosphate starvation


name: negative regulation of cellular response to phosphate starvation


name: mitochondrial proton-transporting ATP synthase complex binding


name: viral entry via permeabilization of host membrane


name: repair of mitotic kinetochore microtubule attachment defect


name: repair of kinetochore microtubule attachment defect


name: regulation of mitotic division septum assembly


name: carbon-nitrogen ligase activity on lipid II


name: pathogen-derived receptor ligand activity


name: intramembrane lipid transporter activity


name: negative regulation of protein localization to medial cortex


name: ATPase-coupled intramembrane lipid transporter activity


name: xenobiotic detoxification by transmembrane export across the cell outer membrane


name: lipopolysaccharide localization to cell outer membrane


name: negative regulation of deacetylase activity


name: regulation of tubulin deacetylase activity


name: positive regulation of tubulin deacetylase activity


name: negative regulation of tubulin deacetylase activity


name: negative regulation of arginase activity


name: positive regulation of arginase activity


name: regulation of protein-glutamine gamma-glutamyltransferase activity


name: positive regulation of protein-glutamine gamma-glutamyltransferase activity


name: negative regulation of protein-glutamine gamma-glutamyltransferase activity


name: positive regulation of neuroinflammatory response


name: negative regulation of neuroinflammatory response


name: multiple spine synapse organization, single dendrite


name: multiple spine synapse organization, multiple dendrites


name: amyloid-beta clearance by cellular catabolic process


name: regulation of microtubule anchoring at centrosome


name: negative regulation of monocyte activation


name: negative regulation of potassium ion import across plasma membrane


name: regulation of iron export across plasma membrane


name: negative regulation of iron export across plasma membrane


name: positive regulation of iron export across plasma membrane


name: regulation of iron ion import across plasma membrane


name: negative regulation of iron ion import across plasma membrane


name: positive regulation of iron ion import across plasma membrane


name: regulation of xenobiotic detoxification by transmembrane export across the plasma membrane


name: negative regulation of xenobiotic detoxification by transmembrane export across the plasma membrane


name: positive regulation of xenobiotic detoxification by transmembrane export across the plasma membrane


name: xenobiotic detoxification by transmembrane export across the plasma membrane


name: xenobiotic transport across blood-brain barrier


name: positive regulation of septum digestion after cytokinesis


name: up regulation of septin assembly and septum biosynthesis involved in mitotic cell cycle


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Zooplastic Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Venous Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Arterial Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Synthetic Substitute, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Nonautologous Tissue Substitute, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Zooplastic Tissue, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Autologous Venous Tissue, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Autologous Arterial Tissue, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Synthetic Substitute, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Nonautologous Tissue Substitute, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery, Open Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Ascending/Arch to Innominate Artery, Percutaneous Endoscopic Approach


name: Insertion of Intraluminal Device into Coronary Artery, One Artery, Open Approach


name: Insertion of Other Device into Coronary Artery, One Artery, Open Approach


name: Insertion of Intraluminal Device into Coronary Artery, One Artery, Percutaneous Approach


name: Insertion of Other Device into Coronary Artery, One Artery, Percutaneous Approach


name: Insertion of Intraluminal Device into Coronary Artery, One Artery, Percutaneous Endoscopic Approach


name: Insertion of Other Device into Coronary Artery, One Artery, Percutaneous Endoscopic Approach


name: Insertion of Intraluminal Device into Coronary Artery, Two Arteries, Open Approach


name: Insertion of Other Device into Coronary Artery, Two Arteries, Open Approach


name: Insertion of Intraluminal Device into Coronary Artery, Two Arteries, Percutaneous Approach


name: Insertion of Other Device into Coronary Artery, Two Arteries, Percutaneous Approach


name: Insertion of Intraluminal Device into Coronary Artery, Two Arteries, Percutaneous Endoscopic Approach


name: Insertion of Other Device into Coronary Artery, Two Arteries, Percutaneous Endoscopic Approach


name: Insertion of Intraluminal Device into Coronary Artery, Three Arteries, Open Approach


name: Insertion of Other Device into Coronary Artery, Three Arteries, Open Approach


name: Insertion of Intraluminal Device into Coronary Artery, Three Arteries, Percutaneous Approach


name: Insertion of Other Device into Coronary Artery, Three Arteries, Percutaneous Approach


name: Insertion of Intraluminal Device into Coronary Artery, Three Arteries, Percutaneous Endoscopic Approach


name: Insertion of Other Device into Coronary Artery, Three Arteries, Percutaneous Endoscopic Approach


name: Insertion of Intraluminal Device into Coronary Artery, Four or More Arteries, Open Approach


name: Insertion of Other Device into Coronary Artery, Four or More Arteries, Open Approach


name: Insertion of Intraluminal Device into Coronary Artery, Four or More Arteries, Percutaneous Approach


name: Insertion of Other Device into Coronary Artery, Four or More Arteries, Percutaneous Approach


name: Insertion of Intraluminal Device into Coronary Artery, Four or More Arteries, Percutaneous Endoscopic Approach


name: Insertion of Other Device into Coronary Artery, Four or More Arteries, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, One Artery with Zooplastic Tissue, Open Approach


name: Supplement Coronary Artery, One Artery with Synthetic Substitute, Open Approach


name: Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, One Artery with Zooplastic Tissue, Percutaneous Approach


name: Supplement Coronary Artery, One Artery with Synthetic Substitute, Percutaneous Approach


name: Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, One Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, One Artery with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Open Approach


name: Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Open Approach


name: Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Percutaneous Approach


name: Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Open Approach


name: Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Open Approach


name: Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Percutaneous Approach


name: Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Open Approach


name: Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Open Approach


name: Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Open Approach


name: Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Percutaneous Approach


name: Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Innominate Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Innominate Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Innominate Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Innominate Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Innominate Artery to Lower Extremity Vein, Open Approach


name: Bypass Right Subclavian Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Right Subclavian Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Right Subclavian Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Right Subclavian Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Right Subclavian Artery to Lower Extremity Vein, Open Approach


name: Bypass Left Subclavian Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Left Subclavian Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Left Subclavian Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Left Subclavian Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Left Subclavian Artery to Lower Extremity Vein, Open Approach


name: Bypass Right Axillary Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Right Axillary Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Right Axillary Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Right Axillary Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Right Axillary Artery to Lower Extremity Vein, Open Approach


name: Bypass Left Axillary Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Left Axillary Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Left Axillary Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Left Axillary Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Left Axillary Artery to Lower Extremity Vein, Open Approach


name: Bypass Right Brachial Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Right Brachial Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Right Brachial Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Right Brachial Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Right Brachial Artery to Lower Extremity Vein, Open Approach


name: Bypass Left Brachial Artery to Lower Extremity Vein with Autologous Venous Tissue, Open Approach


name: Bypass Left Brachial Artery to Lower Extremity Vein with Autologous Arterial Tissue, Open Approach


name: Bypass Left Brachial Artery to Lower Extremity Vein with Synthetic Substitute, Open Approach


name: Bypass Left Brachial Artery to Lower Extremity Vein with Nonautologous Tissue Substitute, Open Approach


name: Bypass Left Brachial Artery to Lower Extremity Vein, Open Approach


name: Bypass Right Ulnar Artery to Lower Arm Vein, Percutaneous Approach


name: Bypass Left Ulnar Artery to Lower Arm Vein, Percutaneous Approach


name: Bypass Right Radial Artery to Lower Arm Vein, Percutaneous Approach


name: Bypass Left Radial Artery to Lower Arm Vein, Percutaneous Approach


name: Restriction of Intracranial Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Intracranial Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Intracranial Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Right Common Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Right Common Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Right Common Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Left Common Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Left Common Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Left Common Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Right Internal Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Right Internal Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Right Internal Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Left Internal Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Left Internal Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Left Internal Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Right External Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Right External Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Right External Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Left External Carotid Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Left External Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Left External Carotid Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Right Vertebral Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Right Vertebral Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Right Vertebral Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Restriction of Left Vertebral Artery with Intraluminal Device, Flow Diverter, Open Approach


name: Restriction of Left Vertebral Artery with Intraluminal Device, Flow Diverter, Percutaneous Approach


name: Restriction of Left Vertebral Artery with Intraluminal Device, Flow Diverter, Percutaneous Endoscopic Approach


name: Occlusion of Gastric Vein with Extraluminal Device, Via Natural or Artificial Opening


name: Occlusion of Gastric Vein with Intraluminal Device, Via Natural or Artificial Opening


name: Occlusion of Gastric Vein, Via Natural or Artificial Opening


name: Occlusion of Gastric Vein with Extraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Occlusion of Gastric Vein with Intraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Occlusion of Gastric Vein, Via Natural or Artificial Opening Endoscopic


name: Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Open Approach


name: Supplement Right Mastoid Sinus with Synthetic Substitute, Open Approach


name: Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Open Approach


name: Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Right Mastoid Sinus with Synthetic Substitute, Percutaneous Approach


name: Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Right Mastoid Sinus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Via Natural or Artificial Opening


name: Supplement Right Mastoid Sinus with Synthetic Substitute, Via Natural or Artificial Opening


name: Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Via Natural or Artificial Opening


name: Supplement Right Mastoid Sinus with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Right Mastoid Sinus with Synthetic Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Right Mastoid Sinus with Nonautologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Left Mastoid Sinus with Autologous Tissue Substitute, Open Approach


name: Supplement Left Mastoid Sinus with Synthetic Substitute, Open Approach


name: Supplement Left Mastoid Sinus with Nonautologous Tissue Substitute, Open Approach


name: Supplement Left Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Left Mastoid Sinus with Synthetic Substitute, Percutaneous Approach


name: Supplement Left Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Approach


name: Supplement Left Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Left Mastoid Sinus with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Supplement Left Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Supplement Left Mastoid Sinus with Autologous Tissue Substitute, Via Natural or Artificial Opening


name: Supplement Left Mastoid Sinus with Synthetic Substitute, Via Natural or Artificial Opening


name: Supplement Left Mastoid Sinus with Nonautologous Tissue Substitute, Via Natural or Artificial Opening


name: Supplement Left Mastoid Sinus with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Left Mastoid Sinus with Synthetic Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Left Mastoid Sinus with Nonautologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic


name: Supplement Accessory Sinus with Autologous Tissue Substitute, Open Approach


name: Supplement Accessory Sinus with Synthetic Substitute, Open Approach


name: Supplement Accessory Sinus with Nonautologous Tissue Substitute, Open Approach


name: Supplement Accessory Sinus with Autologous Tissue Substitute, Percutaneous Approach


name: Supplement Accessory Sinus with Synthetic Substitute, Percutaneous Approach